TrialCardiovascular diabetology2022

Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease.

Efstratios Karagiannidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.